"Dendritic cell therapy is the safest option in cancer treatment and the most effective way for preventing cancer relapse” - Dr. Jamal A. Khan, Director
Please read about the success we have achieved in providing treatment for various types of cancer in various stages.
LIVER CANCER
An 55 year old lady diagnosed with HCC (hepatocellular carcinoma) came to us in November 2006. Her performance status was poor, and had complaints of generalized weakness, nausea and vomiting. Both the liver lobes had lesions. DENVAX therapy was started for her. Her appetite improved, nausea and vomiting subsided and has been ambulatory since then. She gained weight subsequently and her performance status improved. CT scan taken after six months revealed clearance of right lobe lesion and a reduction in size of left lobe lesion. wise. After one year and a half year, her disease started to show progression, for which she was advised chemotherapy. She continued to receive DENVAX therapy for another six months. Her disease is stable till date and is no more receiving any treatment.
HODGKIN'S LYMPHOMA
A 23 year old male patient came to us with mediastinal lymph nodes, mediatinal mass, history of weight loss, excruciating pain in hip (due to lesion in hip joint) with loss of appetite. He was diagnosed of Hodgkin's disease and given numerous doses of chemotherapy but could not stop his disease progression. He was on morphine tablets for pain management. His DENVAX treatment was started in February 2008. By April 2008 he gained 5.5 kg of weight and his pain became bearable. He stopped taking morphine and by the time he received 3rd dose of DENVAX, his radiological report indicated clearing of lymph nodes. He is continuing with DENVAX and is recovering to normalcy.
OVARIAN CANCER
A 58 yr old lady was diagnosed of cancer ovary in June 2004. Her CA 125 antigen marker was positive and in the range of 10,000 units. She was operated upon and given six cycles of chemotherapy. She recovered from her disease and her marker was also within normal range. After one year, the CA 125 began rising and she presented to us with an increased titre of 400 units. There were signs of recurrence, and she opted for DC (DENVAX) therapy in June 2005. She has completed three years of receiving DENVAX. She is free of disease, proven both clinically and by radiological examinations. Her CA 125 marker is also stable for the last three years.
MASTOID CANCER
One of our patient was diagnosed with CA left maxilla in the year 2005. He was operated upon and received chemotherapy as well as radiation. Later, his tumor reappeared at the same site within a gap of six months leading to second surgery and chemotherapy. He decided for DENVAX. He has received 8 doses of DC Vaccine in 18 months and there is no recurrence till date. He is back to his job and is enjoying life by playing badminton for two hours every evening. He continues DENVAX treatment at four month-intervals.
BONE CANCER
A 28 yr old lady was treated for osteosarcoma of right tibia, in 2005. She received radiation and chemotherapy after the amputation of her right leg. Later, she developed metastasis in both lung fields and was again advised for chemotherapy in November 2006. Instead she opted for a combined treatment plan of chemotherapy and Dendritic cell therapy; she has received three cycles of chemotherapy and 7 DC vaccines till date. Her post treatment CT scan reveals normalcy of lung fields. She has been rehabilitated and is back to her normal routine with a near perfect performance status.
LUNG CANCER
A 68 yr old lady came to us in Dec 2005 with left lobe Large cell cancer of the lung with pleural effusion from the same side. She had till then received a single dose of chemotherapy and had refused further doses. Pleural tapping was done and her TAA was identified and stored for DC vaccine preparation. She received 9 doses of DC therapy in a 9 month period. Her PFT improved and also the performance status. CECT remained unremarkable. The pleural fluid was replaced by consolidation. The tumor has not progressed since then and there is no evidence of metastasis to any organ. The patient is surviving and is no more receiving DC vaccines. She is now on passive immunetherapy for the last 12 months.
STOMACH CANCER
A midle aged patient came with the history of carcinoma stomach along with the involvemnt of lower end of esophagus and duodenum. His CT scan depicted extension of disease to adjoining lymph nodes. He was opearted upon without any success due to extensive nature of disease. A feeding jejunostomy tube was installed to avoid starvation as the disease may not allow him to take any more feeds through the oral cavity. He was given palliative chemotherapy but could not tolerate even one cycle. We started dendritic cell therapy and his condition started improving gradually. He was taking his meals even after eight months of diagnosis contrary to the expectations of his doctors. His feeding jejunostomy tube was removed as it remained purposeless. He lived a comfortable life for a year since the diagnosis of advanced and incurable cancer of stomach.
